Bridgewater Associates’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.05M Buy
+95,074
New +$10.1M 0.04% 420

Other funds holding RYTM

Bridgewater Associates's RYTM Position: Q3 2026 in Review

Bridgewater Associates opened a new position in Rhythm Pharmaceuticals (RYTM) in Q3 2026: 95,074 shares worth $9.05M. The stake represents 0.04% of the portfolio and ranks #420 among its holdings.

333 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Bridgewater Associates held 95,074 shares of Rhythm Pharmaceuticals worth $9.05M as of Q3 2026.
  • Rhythm Pharmaceuticals was a new Bridgewater Associates position in Q3 2026.
  • Rhythm Pharmaceuticals made up 0.04% of Bridgewater Associates's portfolio in Q3 2026, its #420 holding.
  • 333 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Bridgewater Associates's 13F filing for Q3 2026, filed 16 Nov 2026.